Harvard Bioscience, Inc. (HBIO) earnings
HBIO earnings moved a median of -0.67% by the close. Quarterly and annual HBIO reports and results, each read against the price at its own news timestamp. Back to the HBIO overview →
34 measured HBIO earnings events.
Where these HBIO earnings landedvs 33 measured HBIO earnings reactions
| Middle 50% of HBIO earnings reactions | -3.49% to +1.92% |
|---|---|
| Median reaction (to close) | -0.67% |
| Measured reactions | 33 |
Point-in-time · zero look-ahead
Half of the 33 HBIO earnings events with a measured close landed between -3.49% and +1.92%; 36% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q HARVARD BIOSCIENCE INC For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -0.96% | |
| Harvard Bioscience Announces Second Quarter 2026 Financial Results | Press release | -4.69% | -5.69% | |
| Harvard Bioscience Schedules Second Quarter 2026 Earnings Conference Call for August 11, 2026 at 8:00 AM ET | Press release | -0.83% | -1.33% | |
| Form 10-Q HARVARD BIOSCIENCE INC For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +1.37% | |
| Harvard Bioscience Announces First Quarter 2026 Financial Results | Press release | -2.46% | -11.31% | |
| Harvard Bioscience Schedules First Quarter 2026 Earnings Conference Call for May 12, 2026 at 8:00 AM ET | Press release | -0.15% | -5.56% | |
| Form 10-K HARVARD BIOSCIENCE INC For: Dec 31 | SEC filing · Form 10-K | +2.13% | +0.74% | |
| Harvard Bioscience Schedules Fourth Quarter 2025 Earnings Conference Call for March 12, 2026 at 8:00 AM ET | Press release | +1.14% | -0.46% | |
| Form 10-Q HARVARD BIOSCIENCE INC For: Sep 30 | SEC filing · Form 10-Q | +2.80% | +5.46% | |
| Harvard Bioscience Announces Third Quarter 2025 Financial Results | Press release | +1.66% | -4.41% | |
| Harvard Bioscience Schedules Third Quarter 2025 Earnings Conference Call for November 6, 2025 at 8:00 AM ET | Press release | -0.96% | +11.90% | |
| Form 10-Q HARVARD BIOSCIENCE INC For: Jun 30 | SEC filing · Form 10-Q | +0.01% | — | |
| Harvard Bioscience Announces Second Quarter 2025 Financial Results | Press release | -3.94% | -6.10% | |
| Harvard Bioscience Schedules Second Quarter 2025 Earnings Conference Call for August 11, 2025 at 8:00 AM ET | Press release | -1.91% | +4.78% | |
| Form 10-Q HARVARD BIOSCIENCE INC For: Mar 31 | SEC filing · Form 10-Q | +1.97% | +4.10% | |
| Harvard Bioscience Announces First Quarter 2025 Financial Results | Press release | -1.65% | -4.84% | |
| Harvard Bioscience Schedules First Quarter 2025 Earnings Conference Call for May 12, 2025 at 8:00 AM ET | Press release | +0.00% | -9.09% | |
| Form 10-K HARVARD BIOSCIENCE INC For: Dec 31 | SEC filing · Form 10-K | +0.00% | -0.32% | |
| Harvard Bioscience Schedules Fourth Quarter 2024 Earnings Conference Call for March 12, 2025 at 8:00 AM ET | Press release | -0.04% | +3.40% | |
| Form 10-Q HARVARD BIOSCIENCE INC For: Sep 30 | SEC filing · Form 10-Q | -1.92% | -6.13% | |
| Harvard Bioscience Announces Third Quarter 2024 Financial Results | Press release | -1.63% | -2.85% | |
| Harvard Bioscience Schedules Third Quarter 2024 Earnings Conference Call for November 7, 2024 at 8:00 AM ET | Press release | +0.00% | +0.00% | |
| Form 10-Q HARVARD BIOSCIENCE INC For: Jun 30 | SEC filing · Form 10-Q | +1.82% | +13.46% | |
| Harvard Bioscience Announces Second Quarter 2024 Financial Results | Press release | +1.82% | +13.46% | |
| Harvard Bioscience Schedules Second Quarter 2024 Earnings Conference Call for August 8, 2024 at 10:00 AM ET | Press release | +0.00% | -0.67% | |
| Form 10-Q HARVARD BIOSCIENCE INC For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +0.82% | |
| Harvard Bioscience Announces First Quarter 2024 Financial Results | Press release | -1.75% | -2.34% | |
| Harvard Bioscience Schedules First Quarter 2024 Earnings Conference Call for May 7, 2024 at 8:00 AM ET | Press release | +0.55% | +1.92% | |
| Form 10-K HARVARD BIOSCIENCE INC For: Dec 31 | SEC filing · Form 10-K | -1.31% | -3.49% | |
| Harvard Bioscience Announces Fourth Quarter 2023 Financial Results | Press release | +4.04% | +11.08% | |
| Harvard Bioscience Schedules Fourth Quarter 2023 Earnings Conference Call for March 7, 2024 at 8:00 AM ET | Press release | +0.00% | +0.00% | |
| Form 10-Q HARVARD BIOSCIENCE INC For: Sep 30 | SEC filing · Form 10-Q | +4.75% | -1.64% | |
| Harvard Bioscience Announces Third Quarter 2023 Financial Results | Press release | +0.00% | -0.93% | |
| Harvard Bioscience Schedules Third Quarter 2023 Earnings Conference Call for November 7, 2023 at 8:00 AM ET | Press release | +0.00% | -0.93% |
Keep exploring
More HBIO: analyst actions → · SEC filings → · HBIO overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| NORTH AMER CANNABIS HLDG (USMJ) | 184 | 0.00% | 32% |
| Cutera, Inc. (CUTR) | 183 | +0.09% | 51% |
| ELEKTA B SHS UNSP/ADR (EKTAY) | 182 | 0.00% | 17% |
| ENDRA Life Sciences Inc. (NDRA) | 181 | -0.92% | 38% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.